Meriva-500 60 Capsules - Thorne Research

Meriva-500 is a unique, patented curcumin product. People throughout Asia have benefited from the healthful effects of curcumin for centuries. Curcumin is the orange pigment in turmeric (the primary ingredient in curry), and is a potent antioxidant that offers numerous health benefits, including supporting joint health and hepatic, GI, and cardiovascular function, by helping to maintain the body's normal inflammatory response.*


These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
If you have a health concern or condition, consult a physician. Always consult a medical doctor before modifying your diet, using any new product or drug supplement.

Two Capsules Contain:
Curcumin Phytosome (Curcuma longa extract (root) / Phosphatidylcholine complex) 1,000 mg
Other Ingredients: Hypromellose (derived from cellulose) capsule, Leucine, CalciumCitrateLaurate, Silicon Dioxide, Microcrystalline Cellulose.

This product uses Indena S.p.A.'s curcumin phytosome (Meriva). Meriva is a registered trademark of Indena S.p.A.

Contains ingredient derived from soy (phytosome).

Suggested Use: Take 1-2 capsules two times daily or as recommended by a health-care practitioner.

ALLERGY WARNINGS
This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients.

Meriva-500 contains curcumin phytosome a plant extract complexed with phosphatidylcholine, which is derived from soy. Phosphatidylcholine contains no soy protein. There are no other soy-based ingredients in Meriva-500.

EXCIPIENT FREE
This product does not contain wheat, gluten, corn, yeast, egg, dairy products, or artificial colors, sweeteners, or flavors. This product also does not contain lactose, palmitic acid, or magnesium, calcium, or vegetable stearates.

PREGNANCY WARNING
If pregnant, consult your health-care practitioner before using this product.

INTERACTIONS/CONTRAINDICATIONS
Curcumin has been shown to reduce the therapeutic efficacy of cyclophosphamide (Cytoxan) in animal studies. In vitro research revealed that curcumin decreased camptothecin-induced death of cultured breast cancer cells. Curcumin might also interfere with the absorption and efficacy of the chemotherapy drug irinotecan, used to treat colon cancer. The concurrent use of curcumin with these agents should be avoided